Cryptocurrencies

MediConnect completes proof-of-concept workflow

MediConnect – a blockchain solution provider for prescription medication – has completed its proof-of-concept (PoC) workflow and has started work on the integration of UK Meds, an online pharmacy, to the MediConnect platform, according to a press release shared with Coin Rivet.

The completed workflow is a significant step forward for MediConnect that establishes a foundation and methodology on which to finalise the PoC, which is designed to track medication through the supply chain from the point at which it is manufactured to its prescription by medical professionals and purchase by patients.

“We are delighted to have completed the workflow for the proof-of-concept, an important milestone in MediConnect’s development. The next step is to complete the integration of UK Meds to our proof-of-concept platform and complete a pilot scheme in 2020,” said MediConnect CEO Dexter Blackstock.

“The pilot scheme will include up to 10 online pharmacies and bring to life our goal of solving the growing issue of overuse of prescription medication, which will help protect the health of patients while reducing costs for the NHS.”

For more news, guides, and cryptocurrency analysis, click here.

Oliver Knight

Londoner ‘Ollie’ graduated from Birmingham City University with a journalism degree in 2016. He combines his writing with his love of crypto and blockchain here at Coin Rivet, saying “It disrupts well-established institutions (banks) while giving an avenue to the less fortunate to achieve financial freedom.” Like all true Londoners, his pet hate is… “People standing on the left-hand side of the escalators on the Tube!”.

Disqus Comments Loading...

Recent Posts

The surge of Bitcoin NFTs: Everything you should know about Bitcoin ordinals

From digital art to real-estate assets, NFTs have become a significant attraction for investors who…

3 weeks ago

MEXC Partners with Aptos to Launch Events Featuring a 1.5 Million USDT Prize Pool

Singapore, Singapore, 21st October 2024, Chainwire

4 weeks ago